Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Innovair
Takeda
Information provided by (Responsible Party):
Laval University
ClinicalTrials.gov Identifier:
NCT01701934
First received: October 3, 2012
Last updated: July 17, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)